Juvenescence, The Buck Institute, and Insilico Medicine establish Napa Therapeutics
Juvenescence, The Buck Institute for Research on Aging, and Insilico Medicine announced today that they have formed Napa Therapeutics, to develop drugs against a novel aging-related target.